My interest in motor neuron disease was sparked by Jørgen, who has been researching and developing treatments for neurodegenerative patients, including those with MND for over a decade.

Scientists say a test for motor neuron disease, based on an aptamer for biomarker TDP-43 in brain tissue, could detect at-risk people before symptoms develop.

A biphasic structural plasticity rule interacts with homeostatic synaptic scaling to maintain firing rate homeostasis in neural networks.